These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 22470120)

  • 1. Evaluation of a mouse model of necrotic granuloma formation using C3HeB/FeJ mice for testing of drugs against Mycobacterium tuberculosis.
    Driver ER; Ryan GJ; Hoff DR; Irwin SM; Basaraba RJ; Kramnik I; Lenaerts AJ
    Antimicrob Agents Chemother; 2012 Jun; 56(6):3181-95. PubMed ID: 22470120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mouse model of necrotic tuberculosis granulomas develops hypoxic lesions.
    Harper J; Skerry C; Davis SL; Tasneen R; Weir M; Kramnik I; Bishai WR; Pomper MG; Nuermberger EL; Jain SK
    J Infect Dis; 2012 Feb; 205(4):595-602. PubMed ID: 22198962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneous disease progression and treatment response in a C3HeB/FeJ mouse model of tuberculosis.
    Lanoix JP; Lenaerts AJ; Nuermberger EL
    Dis Model Mech; 2015 Jun; 8(6):603-10. PubMed ID: 26035868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective Inactivity of Pyrazinamide against Tuberculosis in C3HeB/FeJ Mice Is Best Explained by Neutral pH of Caseum.
    Lanoix JP; Ioerger T; Ormond A; Kaya F; Sacchettini J; Dartois V; Nuermberger E
    Antimicrob Agents Chemother; 2016 Feb; 60(2):735-43. PubMed ID: 26574016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limited activity of clofazimine as a single drug in a mouse model of tuberculosis exhibiting caseous necrotic granulomas.
    Irwin SM; Gruppo V; Brooks E; Gilliland J; Scherman M; Reichlen MJ; Leistikow R; Kramnik I; Nuermberger EL; Voskuil MI; Lenaerts AJ
    Antimicrob Agents Chemother; 2014 Jul; 58(7):4026-34. PubMed ID: 24798275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sterilizing Activity of Pyrazinamide in Combination with First-Line Drugs in a C3HeB/FeJ Mouse Model of Tuberculosis.
    Lanoix JP; Betoudji F; Nuermberger E
    Antimicrob Agents Chemother; 2016 Feb; 60(2):1091-6. PubMed ID: 26643352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Damaging role of neutrophilic infiltration in a mouse model of progressive tuberculosis.
    Marzo E; Vilaplana C; Tapia G; Diaz J; Garcia V; Cardona PJ
    Tuberculosis (Edinb); 2014 Jan; 94(1):55-64. PubMed ID: 24291066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spectinamides are effective partner agents for the treatment of tuberculosis in multiple mouse infection models.
    Robertson GT; Scherman MS; Bruhn DF; Liu J; Hastings C; McNeil MR; Butler MM; Bowlin TL; Lee RB; Lee RE; Lenaerts AJ
    J Antimicrob Chemother; 2017 Mar; 72(3):770-777. PubMed ID: 27999020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PA-824 is as effective as isoniazid against latent tuberculosis infection in C3HeB/FeJ mice.
    Dutta NK; Karakousis PC
    Int J Antimicrob Agents; 2014 Dec; 44(6):564-6. PubMed ID: 25270632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-ranging comparison of rifampin and rifapentine in two pathologically distinct murine models of tuberculosis.
    Rosenthal IM; Tasneen R; Peloquin CA; Zhang M; Almeida D; Mdluli KE; Karakousis PC; Grosset JH; Nuermberger EL
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4331-40. PubMed ID: 22664964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Location of intra- and extracellular M. tuberculosis populations in lungs of mice and guinea pigs during disease progression and after drug treatment.
    Hoff DR; Ryan GJ; Driver ER; Ssemakulu CC; De Groote MA; Basaraba RJ; Lenaerts AJ
    PLoS One; 2011 Mar; 6(3):e17550. PubMed ID: 21445321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug distribution and efficacy of the DprE1 inhibitor BTZ-043 in the C3HeB/FeJ mouse tuberculosis model.
    Ramey ME; Kaya F; Bauman AA; Massoudi LM; Sarathy JP; Zimmerman MD; Scott DWL; Job AM; Miller-Dawson JA; Podell BK; Lyons MA; Dartois V; Lenaerts AJ; Robertson GT
    Antimicrob Agents Chemother; 2023 Nov; 67(11):e0059723. PubMed ID: 37791784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and Improved Resistance Potential of a Cofactor-Independent InhA Inhibitor of Mycobacterium tuberculosis in the C3HeB/FeJ Mouse Model.
    Robertson GT; Ektnitphong VA; Scherman MS; McNeil MB; Dennison D; Korkegian A; Smith AJ; Halladay J; Carter DS; Xia Y; Zhou Y; Choi W; Berry PW; Mao W; Hernandez V; Alley MRK; Parish T; Lenaerts AJ
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30745397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-13-Overexpressing Mice Represent an Advanced Preclinical Model for Detecting the Distribution of Antimycobacterial Drugs within Centrally Necrotizing Granulomas.
    Walter K; Kokesch-Himmelreich J; Treu A; Waldow F; Hillemann D; Jakobs N; Lemm AK; Schwudke D; Römpp A; Hölscher C
    Antimicrob Agents Chemother; 2022 Jun; 66(6):e0158821. PubMed ID: 34871095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Location of persisting mycobacteria in a Guinea pig model of tuberculosis revealed by r207910.
    Lenaerts AJ; Hoff D; Aly S; Ehlers S; Andries K; Cantarero L; Orme IM; Basaraba RJ
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3338-45. PubMed ID: 17517834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The C3HeB/FeJ mouse model recapitulates the hallmark of bovine tuberculosis lung lesions following Mycobacterium bovis aerogenous infection.
    Bouté M; Carreras F; Rossignol C; Doz E; Winter N; Epardaud M
    Vet Res; 2017 Nov; 48(1):73. PubMed ID: 29116026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fighting tuberculosis by drugs targeting nonreplicating
    Iacobino A; Piccaro G; Giannoni F; Mustazzolu A; Fattorini L
    Int J Mycobacteriol; 2017; 6(3):213-221. PubMed ID: 28776518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presence of multiple lesion types with vastly different microenvironments in C3HeB/FeJ mice following aerosol infection with Mycobacterium tuberculosis.
    Irwin SM; Driver E; Lyon E; Schrupp C; Ryan G; Gonzalez-Juarrero M; Basaraba RJ; Nuermberger EL; Lenaerts AJ
    Dis Model Mech; 2015 Jun; 8(6):591-602. PubMed ID: 26035867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High Systemic Exposure of Pyrazinoic Acid Has Limited Antituberculosis Activity in Murine and Rabbit Models of Tuberculosis.
    Lanoix JP; Tasneen R; O'Brien P; Sarathy J; Safi H; Pinn M; Alland D; Dartois V; Nuermberger E
    Antimicrob Agents Chemother; 2016 Jul; 60(7):4197-205. PubMed ID: 27139472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spatial multiomic profiling reveals the novel polarization of foamy macrophages within necrotic granulomatous lesions developed in lungs of C3HeB/FeJ mice infected with
    Seto S; Nakamura H; Guo TC; Hikichi H; Wakabayashi K; Miyabayashi A; Nagata T; Hijikata M; Keicho N
    Front Cell Infect Microbiol; 2022; 12():968543. PubMed ID: 36237431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.